Although the benefits of thrombolytic therapy are well established in patients younger than age 75 years with acute ST-elevation myocardial infarction, the value of thrombolytic treatment in ...

Flow Medical is developing a thrombolysis catheter that delivers TPA through hollow nitinol tubes to treat pulmonary embolism ...

Compared to alteplase, the authors noted, tenecteplase has higher fibrin specificity, a longer half-life, and a simpler, ...

TGD001 is a groundbreaking thrombolytic designed to break down clots of all sizes and compositions – from large clots which cause AIS, down to ‘micro-clots’ which cause conditions such as the rare, ...